SWOG S1418

Primary Category:

Treatment Protocols

Disease Category:

Adjuvant Breast, Breast



A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with > 1 cm Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy

Eligible for screening study DCP 001


S1418 Step 1 Registration re-activated on February 5, 2021 at 12:00 pm Pacific Time.

Site Delegation of Tasks Log required prior to registration of any patients.

Effective June 23, 2020, the BAHO substudy for SWOG study S1418/BR006,  is permanently closed to accrual.